HEADER OXYGEN TRANSPORT 08-JUL-16 5KSJ TITLE CRYSTAL STRUCTURE OF DEOXYGENATED HEMOGLOBIN IN COMPLEX WITH TITLE 2 SPHINGOSINE PHOSPHATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEMOGLOBIN SUBUNIT ALPHA; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: ALPHA-GLOBIN,HEMOGLOBIN ALPHA CHAIN; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: HEMOGLOBIN SUBUNIT BETA; COMPND 7 CHAIN: B, D; COMPND 8 SYNONYM: BETA-GLOBIN,HEMOGLOBIN BETA CHAIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 7 ORGANISM_COMMON: HUMAN; SOURCE 8 ORGANISM_TAXID: 9606 KEYWDS HEMOGLOBIN, SPHINGOSINE-1-PHOSPHATE, COMPLEX, ALLOSTERIC EFFECTOR, KEYWDS 2 OXYGEN TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR M.H.AHMED,M.K.SAFO,Y.XIA REVDAT 4 04-OCT-23 5KSJ 1 REMARK REVDAT 3 04-DEC-19 5KSJ 1 REMARK REVDAT 2 06-DEC-17 5KSJ 1 JRNL REVDAT 1 26-JUL-17 5KSJ 0 JRNL AUTH K.SUN,A.D'ALESSANDRO,M.H.AHMED,Y.ZHANG,A.SONG,T.P.KO, JRNL AUTH 2 T.NEMKOV,J.A.REISZ,H.WU,M.ADEBIYI,Z.PENG,J.GONG,H.LIU, JRNL AUTH 3 A.HUANG,Y.E.WEN,A.Q.WEN,V.BERKA,M.V.BOGDANOV,O.ABDULMALIK, JRNL AUTH 4 L.HAN,A.L.TSAI,M.IDOWU,H.S.JUNEJA,R.E.KELLEMS,W.DOWHAN, JRNL AUTH 5 K.C.HANSEN,M.K.SAFO,Y.XIA JRNL TITL STRUCTURAL AND FUNCTIONAL INSIGHT OF SPHINGOSINE JRNL TITL 2 1-PHOSPHATE-MEDIATED PATHOGENIC METABOLIC REPROGRAMMING IN JRNL TITL 3 SICKLE CELL DISEASE. JRNL REF SCI REP V. 7 15281 2017 JRNL REFN ESSN 2045-2322 JRNL PMID 29127281 JRNL DOI 10.1038/S41598-017-13667-8 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 24093 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1227 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4384 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 208 REMARK 3 SOLVENT ATOMS : 545 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.76 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.62500 REMARK 3 B22 (A**2) : -10.21300 REMARK 3 B33 (A**2) : 16.83800 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.967 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 5.633 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 5.758 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 7.181 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 84.84 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 AUTHOR PROVIDED THE FOLLOWING EVIDENCE OF DIRECT S1P BINDING TO REMARK 3 HEMOGLOBIN: S1P BEADS SUCCESSFULLY PULLED DOWN HBA FROM NORMAL REMARK 3 HUMAN ERYTHROCYTE LYSATES, WHILE SPHINGOSINE OR LYSOPHOSPHATIDIC REMARK 3 ACID BEADS FAILED TO PULL DOWN HB. REMARK 3 IN ADDITION, CO-BINDING OF 2,3-DPG AND S1P TO HEMOGLOBIN (HB) IS REMARK 3 REQUIRED FOR S1P-INDUCED DECREASE IN HB-O2 AFFINITY. WE MEASURED REMARK 3 OXYGEN EQUILIBRATION CURVES (OEC) OF PURIFIED HBA IN THE PRESENCE REMARK 3 OF 2,3-DPG ALONG WITH S1P. WE FOUND THAT S1P DECREASED HBA-O2 REMARK 3 BINDING AFFINITY WITH INCREASED P50 IN A DOSE-DEPENDENT MANNER. REMARK 3 THUS, WE PROVIDE BIOCHEMICAL AND FUNCTIONAL EVIDENCE THAT S1P REMARK 3 BINDS DIRECTLY TO HB BUT REQUIRES COBINDING OF 2,3-DPG TO DECREASE REMARK 3 THE PROTEIN AFFINITY FOR O2 REMARK 4 REMARK 4 5KSJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JUL-16. REMARK 100 THE DEPOSITION ID IS D_1000222680. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-FEB-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : CU FINE FOCUS REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24236 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : 5.080 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.8 REMARK 200 DATA REDUNDANCY IN SHELL : 4.13 REMARK 200 R MERGE FOR SHELL (I) : 0.39800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.8 REMARK 200 STARTING MODEL: 2DN2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM ACETATE TRIHYDRATE, 0.1 M REMARK 280 SODIUM CACODYLATE TRIHYDRATE, PH 6.5 AND 30% PEG 8000, LIQUID REMARK 280 DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 47.59000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.77500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 47.59000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.77500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23550 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -104.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 393 LIES ON A SPECIAL POSITION. REMARK 375 HOH C 420 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O VAL D 11 O HOH D 301 2.14 REMARK 500 O LEU D 32 O HOH D 302 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH C 333 O HOH C 333 2555 2.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 90 -64.24 -121.33 REMARK 500 PRO A 95 -18.74 -46.81 REMARK 500 ALA A 115 -76.92 -54.12 REMARK 500 GLU A 116 3.08 -62.29 REMARK 500 PHE A 117 51.77 -90.48 REMARK 500 THR B 12 -74.08 -48.31 REMARK 500 PRO B 36 -52.08 -29.90 REMARK 500 LEU B 75 9.32 -55.90 REMARK 500 LEU B 78 4.90 -55.06 REMARK 500 ASN B 80 41.08 -151.34 REMARK 500 LYS B 120 -18.63 -47.41 REMARK 500 VAL C 73 -6.97 -53.47 REMARK 500 ASP C 75 32.18 -165.51 REMARK 500 LYS C 90 -76.85 -111.61 REMARK 500 LEU C 113 68.98 -111.84 REMARK 500 TYR D 35 77.20 -110.94 REMARK 500 ASN D 80 44.73 -141.49 REMARK 500 CYS D 93 -61.99 -95.72 REMARK 500 THR D 123 170.39 -54.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 430 DISTANCE = 5.84 ANGSTROMS REMARK 525 HOH A 431 DISTANCE = 5.95 ANGSTROMS REMARK 525 HOH A 432 DISTANCE = 7.13 ANGSTROMS REMARK 525 HOH A 433 DISTANCE = 7.38 ANGSTROMS REMARK 525 HOH B 423 DISTANCE = 5.86 ANGSTROMS REMARK 525 HOH B 424 DISTANCE = 6.40 ANGSTROMS REMARK 525 HOH B 425 DISTANCE = 6.44 ANGSTROMS REMARK 525 HOH C 441 DISTANCE = 5.82 ANGSTROMS REMARK 525 HOH C 442 DISTANCE = 5.96 ANGSTROMS REMARK 525 HOH C 443 DISTANCE = 6.33 ANGSTROMS REMARK 525 HOH C 444 DISTANCE = 6.70 ANGSTROMS REMARK 525 HOH C 445 DISTANCE = 8.34 ANGSTROMS REMARK 525 HOH C 446 DISTANCE = 9.01 ANGSTROMS REMARK 525 HOH C 447 DISTANCE = 10.49 ANGSTROMS REMARK 525 HOH D 439 DISTANCE = 5.98 ANGSTROMS REMARK 525 HOH D 440 DISTANCE = 9.19 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 S1P A 202 REMARK 610 S1P A 203 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 201 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 87 NE2 REMARK 620 2 HEM A 201 NA 99.1 REMARK 620 3 HEM A 201 NB 98.8 88.0 REMARK 620 4 HEM A 201 NC 104.1 156.8 86.5 REMARK 620 5 HEM A 201 ND 104.1 87.4 157.0 88.9 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 201 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 92 NE2 REMARK 620 2 HEM B 201 NA 85.9 REMARK 620 3 HEM B 201 NB 101.2 86.9 REMARK 620 4 HEM B 201 NC 117.2 156.8 88.3 REMARK 620 5 HEM B 201 ND 91.5 90.9 166.9 88.7 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM C 201 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS C 87 NE2 REMARK 620 2 HEM C 201 NA 95.3 REMARK 620 3 HEM C 201 NB 89.2 86.7 REMARK 620 4 HEM C 201 NC 107.0 157.1 88.5 REMARK 620 5 HEM C 201 ND 112.6 89.0 158.1 87.2 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM D 201 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 92 NE2 REMARK 620 2 HEM D 201 NA 90.5 REMARK 620 3 HEM D 201 NB 98.8 89.9 REMARK 620 4 HEM D 201 NC 106.9 162.3 90.3 REMARK 620 5 HEM D 201 ND 90.5 88.7 170.6 88.2 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HEM A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue S1P A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue S1P A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HEM B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HEM C 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HEM D 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5KSI RELATED DB: PDB DBREF 5KSJ A 1 141 UNP P69905 HBA_HUMAN 2 142 DBREF 5KSJ B 1 146 UNP P68871 HBB_HUMAN 2 147 DBREF 5KSJ C 1 141 UNP P69905 HBA_HUMAN 2 142 DBREF 5KSJ D 1 146 UNP P68871 HBB_HUMAN 2 147 SEQRES 1 A 141 VAL LEU SER PRO ALA ASP LYS THR ASN VAL LYS ALA ALA SEQRES 2 A 141 TRP GLY LYS VAL GLY ALA HIS ALA GLY GLU TYR GLY ALA SEQRES 3 A 141 GLU ALA LEU GLU ARG MET PHE LEU SER PHE PRO THR THR SEQRES 4 A 141 LYS THR TYR PHE PRO HIS PHE ASP LEU SER HIS GLY SER SEQRES 5 A 141 ALA GLN VAL LYS GLY HIS GLY LYS LYS VAL ALA ASP ALA SEQRES 6 A 141 LEU THR ASN ALA VAL ALA HIS VAL ASP ASP MET PRO ASN SEQRES 7 A 141 ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS LEU SEQRES 8 A 141 ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS CYS SEQRES 9 A 141 LEU LEU VAL THR LEU ALA ALA HIS LEU PRO ALA GLU PHE SEQRES 10 A 141 THR PRO ALA VAL HIS ALA SER LEU ASP LYS PHE LEU ALA SEQRES 11 A 141 SER VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 B 146 VAL HIS LEU THR PRO GLU GLU LYS SER ALA VAL THR ALA SEQRES 2 B 146 LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY GLU SEQRES 3 B 146 ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 B 146 ARG PHE PHE GLU SER PHE GLY ASP LEU SER THR PRO ASP SEQRES 5 B 146 ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY LYS SEQRES 6 B 146 LYS VAL LEU GLY ALA PHE SER ASP GLY LEU ALA HIS LEU SEQRES 7 B 146 ASP ASN LEU LYS GLY THR PHE ALA THR LEU SER GLU LEU SEQRES 8 B 146 HIS CYS ASP LYS LEU HIS VAL ASP PRO GLU ASN PHE ARG SEQRES 9 B 146 LEU LEU GLY ASN VAL LEU VAL CYS VAL LEU ALA HIS HIS SEQRES 10 B 146 PHE GLY LYS GLU PHE THR PRO PRO VAL GLN ALA ALA TYR SEQRES 11 B 146 GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA HIS SEQRES 12 B 146 LYS TYR HIS SEQRES 1 C 141 VAL LEU SER PRO ALA ASP LYS THR ASN VAL LYS ALA ALA SEQRES 2 C 141 TRP GLY LYS VAL GLY ALA HIS ALA GLY GLU TYR GLY ALA SEQRES 3 C 141 GLU ALA LEU GLU ARG MET PHE LEU SER PHE PRO THR THR SEQRES 4 C 141 LYS THR TYR PHE PRO HIS PHE ASP LEU SER HIS GLY SER SEQRES 5 C 141 ALA GLN VAL LYS GLY HIS GLY LYS LYS VAL ALA ASP ALA SEQRES 6 C 141 LEU THR ASN ALA VAL ALA HIS VAL ASP ASP MET PRO ASN SEQRES 7 C 141 ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS LEU SEQRES 8 C 141 ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS CYS SEQRES 9 C 141 LEU LEU VAL THR LEU ALA ALA HIS LEU PRO ALA GLU PHE SEQRES 10 C 141 THR PRO ALA VAL HIS ALA SER LEU ASP LYS PHE LEU ALA SEQRES 11 C 141 SER VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 D 146 VAL HIS LEU THR PRO GLU GLU LYS SER ALA VAL THR ALA SEQRES 2 D 146 LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY GLU SEQRES 3 D 146 ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 D 146 ARG PHE PHE GLU SER PHE GLY ASP LEU SER THR PRO ASP SEQRES 5 D 146 ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY LYS SEQRES 6 D 146 LYS VAL LEU GLY ALA PHE SER ASP GLY LEU ALA HIS LEU SEQRES 7 D 146 ASP ASN LEU LYS GLY THR PHE ALA THR LEU SER GLU LEU SEQRES 8 D 146 HIS CYS ASP LYS LEU HIS VAL ASP PRO GLU ASN PHE ARG SEQRES 9 D 146 LEU LEU GLY ASN VAL LEU VAL CYS VAL LEU ALA HIS HIS SEQRES 10 D 146 PHE GLY LYS GLU PHE THR PRO PRO VAL GLN ALA ALA TYR SEQRES 11 D 146 GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA HIS SEQRES 12 D 146 LYS TYR HIS HET HEM A 201 43 HET S1P A 202 18 HET S1P A 203 18 HET HEM B 201 43 HET HEM C 201 43 HET HEM D 201 43 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM S1P (2S,3R,4E)-2-AMINO-3-HYDROXYOCTADEC-4-EN-1-YL HETNAM 2 S1P DIHYDROGEN PHOSPHATE HETSYN HEM HEME HETSYN S1P SPHINGOSINE 1-PHOSPHATE FORMUL 5 HEM 4(C34 H32 FE N4 O4) FORMUL 6 S1P 2(C18 H38 N O5 P) FORMUL 11 HOH *545(H2 O) HELIX 1 AA1 SER A 3 LYS A 16 1 14 HELIX 2 AA2 VAL A 17 ALA A 19 5 3 HELIX 3 AA3 HIS A 20 PHE A 36 1 17 HELIX 4 AA4 PRO A 37 PHE A 43 5 7 HELIX 5 AA5 SER A 52 HIS A 72 1 21 HELIX 6 AA6 ASP A 75 LEU A 80 1 6 HELIX 7 AA7 LEU A 80 LYS A 90 1 11 HELIX 8 AA8 ASN A 97 ALA A 111 1 15 HELIX 9 AA9 THR A 118 SER A 138 1 21 HELIX 10 AB1 THR B 4 GLY B 16 1 13 HELIX 11 AB2 ASN B 19 TYR B 35 1 17 HELIX 12 AB3 PRO B 36 GLY B 46 5 11 HELIX 13 AB4 THR B 50 GLY B 56 1 7 HELIX 14 AB5 ASN B 57 LEU B 75 1 19 HELIX 15 AB6 ASN B 80 PHE B 85 1 6 HELIX 16 AB7 PHE B 85 LYS B 95 1 11 HELIX 17 AB8 PRO B 100 GLY B 119 1 20 HELIX 18 AB9 LYS B 120 PHE B 122 5 3 HELIX 19 AC1 THR B 123 LYS B 144 1 22 HELIX 20 AC2 SER C 3 GLY C 18 1 16 HELIX 21 AC3 HIS C 20 PHE C 36 1 17 HELIX 22 AC4 PRO C 37 PHE C 43 5 7 HELIX 23 AC5 SER C 52 HIS C 72 1 21 HELIX 24 AC6 ASP C 75 LEU C 80 1 6 HELIX 25 AC7 LEU C 80 LYS C 90 1 11 HELIX 26 AC8 PRO C 95 LEU C 113 1 19 HELIX 27 AC9 THR C 118 THR C 137 1 20 HELIX 28 AD1 THR D 4 GLY D 16 1 13 HELIX 29 AD2 ASN D 19 TYR D 35 1 17 HELIX 30 AD3 PRO D 36 GLY D 46 5 11 HELIX 31 AD4 THR D 50 GLY D 56 1 7 HELIX 32 AD5 ASN D 57 LEU D 75 1 19 HELIX 33 AD6 ASN D 80 PHE D 85 1 6 HELIX 34 AD7 PHE D 85 LYS D 95 1 11 HELIX 35 AD8 PRO D 100 GLY D 119 1 20 HELIX 36 AD9 LYS D 120 PHE D 122 5 3 HELIX 37 AE1 THR D 123 LYS D 144 1 22 LINK NE2 HIS A 87 FE HEM A 201 1555 1555 2.08 LINK NE2 HIS B 92 FE HEM B 201 1555 1555 2.07 LINK NE2 HIS C 87 FE HEM C 201 1555 1555 2.09 LINK NE2 HIS D 92 FE HEM D 201 1555 1555 2.01 SITE 1 AC1 18 TYR A 42 PHE A 43 HIS A 45 PHE A 46 SITE 2 AC1 18 HIS A 58 LYS A 61 LEU A 83 LEU A 86 SITE 3 AC1 18 HIS A 87 LEU A 91 VAL A 93 ASN A 97 SITE 4 AC1 18 PHE A 98 LEU A 101 LEU A 136 HOH A 308 SITE 5 AC1 18 HOH A 337 LYS D 17 SITE 1 AC2 7 PHE A 36 LYS A 99 LEU A 100 S1P A 203 SITE 2 AC2 7 ASN B 108 HOH B 301 HOH B 310 SITE 1 AC3 8 PHE A 36 LYS A 99 S1P A 202 HOH A 333 SITE 2 AC3 8 HOH A 353 HOH A 365 HOH B 301 HOH B 310 SITE 1 AC4 16 LYS A 56 HOH A 323 PHE B 42 HIS B 63 SITE 2 AC4 16 LYS B 66 VAL B 67 ALA B 70 PHE B 85 SITE 3 AC4 16 HIS B 92 LEU B 96 ASN B 102 LEU B 106 SITE 4 AC4 16 LEU B 141 HOH B 320 HOH B 321 HOH B 326 SITE 1 AC5 17 TYR C 42 PHE C 43 HIS C 45 PHE C 46 SITE 2 AC5 17 HIS C 58 LYS C 61 LEU C 83 LEU C 86 SITE 3 AC5 17 HIS C 87 LEU C 91 VAL C 93 ASN C 97 SITE 4 AC5 17 PHE C 98 LEU C 101 LEU C 136 HOH C 308 SITE 5 AC5 17 HOH C 328 SITE 1 AC6 13 HIS C 72 LEU D 31 HIS D 63 LYS D 66 SITE 2 AC6 13 VAL D 67 LEU D 88 HIS D 92 LEU D 96 SITE 3 AC6 13 ASN D 102 PHE D 103 LEU D 106 LEU D 141 SITE 4 AC6 13 HOH D 321 CRYST1 95.180 97.550 65.030 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010506 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010251 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015378 0.00000